H.R. 2715 Congress 119 session
Destruction of Hazardous Imports Act
Destruction of Hazardous Imports Act This bill expands the Food and Drug Administration’s (FDA’s) authority to require the destruction of certain items that are refused import into the United States and pose a risk to public health. Under current law, imported food, drugs, medical devices, tobacco products, and cosmetics are subject to FDA review. If an imported item is deficient in a specified manner (e.g., counterfeit, misbranded, or manufactured under insanitary conditions), the item is generally refused admission to the United States. An item refused admission may generally be exported, except that the FDA may destroy a drug, medical device, or tobacco product that is valued under $2,500 without the opportunity for export. Under the bill, the FDA may order the destruction, without the opportunity for export, of any food, drug, medical device, tobacco product, or cosmetic that is refused admission if the item presents a significant public health concern. If such an order is issued, the item’s owner or consignee must destroy it within 90 days at their own cost. The bill also prohibits the unauthorized movement (e.g., export) of an item subject to a destruction order. A violator is subject to a fine, a prison term of up to one year, or both. The FDA must promulgate regulations to carry out these provisions. These regulations must provide for due process for the owner or consignee of an item subject to a destruction order, including notice and an opportunity to appear before the item is destroyed.
Status
- Introduced
- Committee
- Floor vote
- Passed
- Enacted
Passed one chamber — last recorded action July 21, 2026
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Passage likelihood
79% Higher than most bills at this stage
This is an estimate, not a guarantee. It is computed from the signals listed below and nothing else. It does not account for leadership priorities, floor scheduling, or negotiations that are not in the public record.
What the estimate is based on
- Historical base rate About 4% of introduced federal bills are enacted.
- Current stage Passed one chamber.
- Cosponsors 18 cosponsors.
- Bipartisan cosponsorship Cosponsors come from 2 parties.
State-level impact
State-level impact data is not available for this bill. The source text does not contain a per-state funding formula or scored breakdown, so no figures are shown.
Official actions
- Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Motion to reconsider laid on the table Agreed to without objection.
- On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4637-4638)
- Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4637-4638)
- DEBATE - The House proceeded with forty minutes of debate on H.R. 2715.
- Considered under suspension of the rules. (consideration: CR H4637-4639)
- Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
- Placed on the Union Calendar, Calendar No. 613.
- Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-705.
- Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-705.
- Ordered to be Reported (Amended) by the Yeas and Nays: 43 - 0.
- Committee Consideration and Mark-up Session Held
- Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote.
- Subcommittee Consideration and Mark-up Session Held
- Referred to the Subcommittee on Health.
- Referred to the House Committee on Energy and Commerce.
- Introduced in House
- Introduced in House